Ridgeback Capital Investments L.P. Quant / Systematic

Name: Ridgeback Capital Investments L.P. Q4 2018 13F Filing | 13F Explorer
Creator: Ridgeback Capital Investments L.P.
Published: 2019-02-14

Location: Miami Beach, FL

CIK: 0001423994 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 14, 2019

Total Value: $36.97M (100.0% shares, 0.0% debt)

Holdings (1)

— KARYOPHARM THERAPEUTICS INC. 100.0%

Value $36.97M Shares 3,945,200 Est. Cost $9.37 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	KARYOPHARM THERAPEUTICS INC.	3,945,200	$36.97M	100.0%	$9.37	—	COM	48576U106